Champions Oncology Stock Guidance | NASDAQ:CSBR

Comments

Champions Oncology Inc Stock Guidance

CSBRNASDAQ

Trade with Public

$6.20

-0.05-0.80%

At close: Mar 17, 5:00 PM EST

$5.96

-0.24-3.87%

After Hours: Mar 2, 7:00 AM EST

Earnings: Q3 2026 Earnings were released on Thu Mar 12th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 5 days ago

Click to view the webcast

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Champions Oncology (CSBR) last issued guidance on July 21, 2022 for fiscal year 2023. The company guided revenue in the range of $58.93M - $58.93M for the period.

Latest Guidance Date

Jul 21, 2022

Guidance Period

Full Year 2023

Revenue Guidance Range

$58.93M - $58.93M

Champions Oncology Guidance History

Review all historical guidance issued by Champions Oncology, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Champions Oncology (CSBR)?

The most recent guidance for Champions Oncology (CSBR) was reported on July 21, 2022 for the fiscal year 2023. Champions Oncology forecasted revenue between $58.93M and $58.93M for the period.

What revenue range did Champions Oncology (CSBR) guide for?

Champions Oncology (CSBR) guided revenue in the range of $58.93M to $58.93M for the fiscal year 2023.

When did Champions Oncology (CSBR) last issue guidance?

Champions Oncology (CSBR) last issued guidance on July 21, 2022 for the fiscal year 2023.

People Also Watch

Harvard Bioscience Inc

Lifecore Biomedical Inc

NASDAQ:LFCR

$4.45

2.02%

Atlantic International Corp

Standard BioTools Inc

NASDAQ:LAB

$0.98